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3-end cleavage of histone pre-mRNAs is catalyzed by CPSF-73 and requires the interaction of two U7 snRNP-
associated proteins, FLASH and Lsm11. Here, by using scanning mutagenesis we identify critical residues in human
FLASH and Lsm11 that are involved in the interaction between these two proteins. We also demonstrate that
mutations in the region of FLASH located between amino acids 50 and 99 do not affect binding of Lsm11.
Interestingly, these mutations convert FLASH into an inhibitory protein that reduces in vitro processing efficiency
of highly active nuclear extracts. Our results suggest that this region in FLASH in conjunction with Lsm11 is
involved in recruiting a yet-unknown processing factor(s) to histone pre-mRNA. Following endonucleolytic cleavage
of histone pre-mRNA, the downstream cleavage product (DCP) is degraded by the 5–3 exonuclease activity of
CPSF-73, which also depends on Lsm11. Strikingly, while cleavage of histone pre-mRNA is stimulated by FLASH
and inhibited by both dominant negative mutants of FLASH and anti-FLASH antibodies, the 5–3 degradation of
the DCP is not affected. Thus, the recruitment of FLASH to the processing complex plays a critical role in activating
the endonuclease mode of CPSF-73 but is dispensable for its 5–3 exonuclease activity. These results suggest that
CPSF-73, the catalytic component in both reactions, can be recruited to histone pre-mRNA largely in a manner
independent of FLASH, possibly by a separate domain in Lsm11.
Animal replication-dependent histone pre-mRNAs are pro-
cessed at the 3 end by an endonucleolytic cleavage that is not
followed by polyadenylation (3, 4). The reaction depends on
two sequence elements: a highly conserved stem-loop structure
and a divergent sequence referred to as the histone down-
stream element (HDE) that begins approximately 15 nucleo-
tides 3 of the stem. Histone pre-mRNAs are cleaved between
the two sequence elements, resulting in the formation of ma-
ture histone mRNAs ending with the stem-loop followed by an
ACCCA single-stranded tail (Fig. 1A). In vitro, the down-
stream cleavage product (DCP) is rapidly degraded in the 5 to
3 direction (19, 21). This activity may play an important role in
recycling the U7 snRNP and terminating transcription on his-
tone genes (21).
The stem-loop interacts with the stem-loop binding protein
(SLBP), whereas the HDE base pairs with the 5 end of U7
snRNA, the approximately 60-nucleotide component of the U7
snRNP (3). The U7 snRNA associates with a unique Sm com-
plex in which Lsm10 and Lsm11 substitute for SmD1 and
SmD2, two canonical proteins found in the spliceosomal
snRNPs (13, 14). The cleavage reaction is catalyzed by
CPSF-73 (6) and requires at least two other factors shared with
cleavage/polyadenylation: symplekin and CPSF-100 (9, 10, 17).
CPSF-73, in addition to its endonuclease activity (12), displays
a 5–3 exonuclease activity that is responsible for degradation of
the DCP in histone pre-mRNA (21). In mammalian nuclear ex-
tracts, cleavage of histone pre-mRNAs can occur in the absence
of SLBP if the U7 snRNA has sufficient complementarity to the
HDE, suggesting that SLBP stabilizes the association of the U7
snRNP with the pre-mRNA substrate (7, 16). This function of
SLBP is likely mediated by ZFP100, which interacts with both the
SLBP/stem-loop complex (2) and Lsm11 (1, 18).
Lsm10 and two common proteins of the U7 Sm complex,
SmB and SmD3, interact with the region in histone pre-mRNA
located between the cleavage site and the HDE (22). These
interactions are predicted to position Lsm11 near the site of
cleavage. Lsm11 interacts with FLASH (20), a 220-kDa protein
initially identified as an activator of caspase 8 (8). FLASH is an
essential component of the U7-dependent machinery in verte-
brates and invertebrates, but its specific function in processing
remains unknown (20).
In order to determine the role of FLASH in 3-end processing,
we carried out a detailed analysis of the N-terminal portions of
FLASH and Lsm11 that are involved in 3-end processing of
histone pre-mRNAs. We mapped the interacting regions in
FLASH and Lsm11 and identified a sequence in FLASH that
binds a yet-undetermined processing factor(s). We also show that
FLASH is critical for the endonucleolytic cleavage of histone
pre-mRNAs but is dispensable for the 5 to 3 exonucleolytic
degradation of the downstream cleavage product.
MATERIALS AND METHODS
RNA substrates. The 86-nucleotide H2a-614 pre-mRNA containing all neces-
sary processing sequence elements was generated by transcribing an appropriate
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DNA template using T7 RNA polymerase. The 30-nucleotide DCP RNA was
synthesized by Dharmacon (Lafayette, CO). The H2a pre-mRNA was treated
with calf intestinal phosphatase (New England Biolabs [NEB]), extracted with
phenol, and labeled at the 5 end with 32P using T4 polynucleotide kinase (NEB).
The DCP RNA was directly labeled at the 5 end without prior phosphatase
treatment.
Mutagenesis and protein expression. Mutations in FLASH and Lsm11 were
generated using PCR and appropriately altered oligonucleotide primers. Mu-
tated FLASH cDNA fragments were inserted into the pET-42a vector, and
mutant proteins were expressed in the BL21 Escherichia coli strain as fusions
with glutathione S-transferase (GST). All bacterially expressed FLASH proteins
contained a single amino acid substitution, replacing threonine in position 99
with alanine, as originally cloned in the yeast two-hybrid screen using the Lsm11
bait (20). However, this substitution is located in a region of relatively low
conservation and has no effect on the processing activity of FLASH. The wild-
type and mutant versions of the N-terminal fragment of human Lsm11 (amino
acids 1 to 170) were expressed and labeled with [35S]methionine using the TnT
kit (Promega), as recommended by the manufacturer. The same method was
used to synthesize full-length ZFP100, symplekin, CPSF-73, and CPSF-100.
In vitro 3-end processing. All processing reactions were carried out in mouse
nuclear extracts prepared from myeloma cells, as described previously (5). The
86-nucleotide H2a histone pre-mRNA was used as the substrate in the cleavage
reaction, whereas the 30-nucleotide RNA corresponding to the DCP was used as
the substrate for the 5–3 exonuclease degradation. Each reaction mixture was
prepared in a final volume of 10 l and contained 20 mM EDTA, 0.05 pmol of
a 5-labeled RNA substrate, and 0.5 to 7.5 l of the nuclear extract. Nuclear
extracts were supplemented with 0.5 l of an antibody or 100 ng of a recombinant
FLASH-GST fusion protein, as indicated. Depending on the experiment, pro-
cessing samples were incubated from 15 to 90 min at 32°C and subsequently
treated for 1 h at 37°C with proteinase K–0.05% SDS. Samples were mixed with
30 l of a loading dye containing 8 M urea and analyzed on 8% polyacrylamide–8
M urea gels. The radioactive RNA was detected by autoradiography.
In vitro binding assay. Various deletion or point mutants of the N-terminal
FLASH (amino acids 1 to 139) were expressed in E. coli as fusion proteins with
GST and tested for the ability to bind 35S-labeled N-terminal human Lsm11
(amino acids 1 to 170), as described previously (20). Protein complexes were
adsorbed on glutathione beads and separated on an SDS-polyacrylamide gel,
followed by detection of the bound 35S-labeled protein by autoradiography. The
FIG. 1. Mutational analysis of the region of Lsm11 required for the interaction with FLASH. (A) Sequences and factors involved in 3-end
processing of histone pre-mRNA. The HDE that base pairs with the 5 end of the U7 snRNA (thick gray line) is underlined, and the site of cleavage
located 5 nucleotides after the stem-loop is indicated with an arrow. The fragment of histone pre-mRNA located downstream of the cleavage site
is referred to as the DCP. (B) Sequence alignment of the N-terminal half of human (top) and Drosophila (bottom) Lsm11. Residues of human
Lsm11 that were changed to alanines are underlined. The PL dipetide located in positions 33 and 34 is referred to as PL1, whereas the
more-downstream dipeptide at positions 155 and 156 is referred to as PL2. (C and D) Pulldown of 35S-labeled wild-type and mutant versions of
the N-terminal fragment of Lsm11 by GST or GST fused to the N-terminal fragment (amino acids 1 to 139) of human FLASH, as indicated.
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amount of recovered GST protein was monitored prior to autoradiography by
staining gels with Coomassie blue. Each binding assay was performed at least two
to three times.
RESULTS
Mutational analysis of the region of Lsm11 required for the
interaction with FLASH. Lsm11 contains an extended N-ter-
minal domain of 170 amino acids that is unusual for members
of the Sm/Lsm family (15) and plays a key role in 3-end
processing of histone pre-mRNAs (1). The first 40 amino acids
of this unique domain are essential for the interaction with
FLASH (20). We introduced a number of point mutations
within a patch of amino acids located between amino acids 27
and 40 that are highly conserved between mammalian and
Drosophila melanogaster Lsm11 (Fig. 1B). All mutations were
generated in the N-terminal portion of Lsm11 (amino acids 1
to 170), and 35S-labeled mutant proteins were tested for their
ability to interact with the N-terminal human FLASH (amino
acids 1 to 139) fused to GST. FLASH-GST consistently bound
around 20% of the total amount of the wild-type N-terminal
Lsm11 used in the assay, whereas GST itself was unable to bind
this fragment of Lsm11 (Fig. 1C, all panels, lane 2). Mutating
the LDV at the beginning of the conserved 14-amino-acid
patch in Lsm11 to AAA reduced the interaction with FLASH
to about 25% of the wild-type level (Fig. 1C, panel 2). A more
dramatic effect was achieved by the FD-AA mutation in the
middle of the patch, which nearly abolished the interaction
between the two proteins (Fig. 1C, panel 3). Mutating the
neighboring PL (PL1 mutation) reduced the binding to 45%
of the wild-type level (Fig. 1C, panel 4), whereas substitution of
the LY near the end of the patch to AA had no effect on the
interaction between Lsm11 and FLASH (Fig. 1C, panel 5).
We also introduced alanine substitutions in other parts of
the N-terminal Lsm11 and tested their effects on the interac-
tion with FLASH. Of particular interest were the MPL (amino
acids 149 to 151) and PER (amino acids 107 to 109) clusters
that were previously found to be essential for processing in
Xenopus tropicalis oocytes (1). However, mutations within
these tripeptides did not affect the in vitro interaction of Lsm11
with FLASH (Fig. 1D, lanes 5 and 7), suggesting that they
contact different processing factors. No effect on the interac-
tion was caused by substituting the PL dipeptide at positions
156 to 157 with alanines (Fig. 1C, panel 6, PL2 mutation). This
dipeptide is conserved in all known putative Lsm11 orthologs,
but its role in 3-end processing has not been studied.
Mapping the region of FLASH required for the interaction
with Lsm11. The N-terminal region of human FLASH (amino
acids 1 to 139) stimulates in vitro processing of histone pre-
mRNAs (20). The stimulatory effect is most evident when the
reaction is carried out in the presence of small amounts of a
mouse nuclear extract (0.5 to 0.75 l per reaction mixture).
Under these suboptimal conditions, typically less than 10% of
the input substrate is converted to the mature product, and
adding 100 ng of the N-terminal FLASH fused to GST in-
creases the processing efficiency to 50%. We previously
showed that the N-terminal region of Drosophila FLASH does
not stimulate processing in a mouse nuclear extract, although
it binds human Lsm11 (20). We tested whether the N-terminal
region of FLASH (amino acids 1 to 141) from a distantly
related vertebrate, Xenopus tropicalis, can substitute for human
FLASH. The human and Xenopus FLASH are relatively diver-
gent in the first 50 amino acids but share strong similarity in
the next 90 amino acids (Fig. 2A; see also Fig. S1 in the
supplemental material). The N-terminal fragment of the
Xenopus protein clearly stimulated processing in a mouse nu-
clear extract, although its effect was slightly weaker than that of
the human protein (Fig. 2B, lanes 3 and 4). This result indi-
cates that Xenopus FLASH supports all essential functions
required for processing in mouse nuclear extracts, including
the interaction with Lsm11.
To determine whether the highly conserved cluster of amino
acids located at positions 29 to 33 of human FLASH (Fig. 2A)
plays any role in processing, we mutated the dipeptide LD
(amino acids 30 and 31) to alanines within the 139-amino-acid
fragment of FLASH. The resultant LD1 mutant protein re-
tained the ability to stimulate processing in vitro (Fig. 2C, lane
4) and to bind Lsm11 (data not shown). An N-terminal dele-
tion removing the first 28 amino acids of FLASH (28N) had
no effect on either binding to Lsm11 (Fig. 2D, lane 4) or
processing in vitro (Fig. 2F, lane 4). In contrast, a mutant
FLASH additionally lacking the last 11 amino acids (28N/
11C) had a reduced ability to interact with Lsm11 (Fig. 2E,
lane 4) and to stimulate the cleavage activity of a nuclear
extract (Fig. 2G, lane 4). An even more significant effect was
achieved by deleting 20 amino acids from the C terminus of
human FLASH. The 28N/20C FLASH mutant retained only
residual ability to bind Lsm11 (Fig. 2E, lane 5) and was fully
inactive in processing (Fig. 2G, lane 5). We conclude that the
first 28 amino acids of FLASH are dispensable for processing,
and the Lsm11 binding site likely occupies the C-terminal
region of the 139-amino-acid fragment of FLASH.
Mutational analysis of the Lsm11 binding site in FLASH.
The distal portion of the 139-amino-acid fragment of FLASH
is the most conserved region of the entire protein. Human and
Drosophila FLASH orthologs share 30% identity and over 60%
similarity within the region spanning from residues 100 to 135
(Fig. 3A; numbering for the human protein). Since both pro-
teins are capable of interacting with human Lsm11, we re-
placed a number of conserved amino acids located in this short
region of human FLASH with alanines. All mutant proteins
were expressed as GST fusions and tested for their abilities to
interact with the N-terminal fragment of Lsm11 and to stimu-
late in vitro processing.
Replacing asparagine 101 near the beginning of the con-
served region with alanine (N101A) had no effect on the bind-
ing to Lsm11 (Fig. 3B, lane 4) or the ability to stimulate in vitro
processing (Fig. 3D, lane 4), whereas replacing LK at positions
111 to 112 (LK-AA) significantly reduced, but did not abolish,
the activity of FLASH either assay (Fig. 3B, lane 5, and D, lane
5). When combined, these two mutations (N and LK) had a
larger effect, reducing the interaction of FLASH with Lsm11 to
a background level (Fig. 3B, lane 6) and virtually eliminating
the processing activity of FLASH (Fig. 3D, lane 6).
A similarly harmful effect was achieved by replacing the LI
dipeptide (amino acids 118 and 119) with two alanines (LI-
AA). This mutation, located close to the middle of the con-
served region, nearly abolished the ability of FLASH to bind
Lsm11 (Fig. 3C, lane 5) and to stimulate in vitro processing
(Fig. 3E, lane 6). The KD-AA mutation (amino acids 129 and
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130) moderately reduced Lsm11 binding (Fig. 3C, lane 6) and
showed only a slightly negative effect on the processing activity
of FLASH (Fig. 3E, lane 7). The L136A mutation located near
the end of the conserved region had no effect on either assay
(Fig. 3C, lane 3, and E, lane 8). Based on the phenotypes of
both deletion and point mutants, we conclude that the core of
the Lsm11 binding site in human FLASH is located between
amino acids 101 and 119. A significant role in binding Lsm11 is
also played by a more distal region, extending at least to the
conserved KD dipetide at positions 129 and 130.
We also tested whether FLASH mutants with a reduced
ability to bind Lsm11 have an inhibitory effect on processing,
since they could potentially interact with other factors and act
in a dominant negative fashion. In vitro processing reactions
were carried out with the optimal amount of the nuclear ex-
tract (7.5 l), but the incubation time was shortened from 1.5 h
to only 15 min. Under these conditions, the 28N/20C, LI-AA,
or NLK FLASH mutants had no effect on the efficiency of
processing (Fig. 3F, lanes 4, 8, and 9, respectively). We con-
clude that mutations within FLASH that reduce or abolish its
interaction with Lsm11 do not result in a dominant negative
phenotype.
Identification of a second region in FLASH required for
processing. Our hypothesis was that FLASH is recruited to
the processing complex by Lsm11 and interacts with one or
more processing factors to execute its role in the cleavage
reaction. To map the binding site for this undetermined fac-
tor(s) and as a first step toward revealing its identity, we ex-
pressed a number of human FLASH proteins successively
shortened from the N terminus (Fig. 4A) and tested their
abilities to stimulate in vitro processing and bind Lsm11. De-
leting the first 36 or 51 amino acids of the FLASH N-terminal
region did not reduce either processing (Fig. 4B, lanes 4 and 5)
or binding activity (Fig. 4C, lanes 4 and 5). Together with the
lack of any effect of the LD1 mutation (Fig. 2C, lane 4), these
data demonstrate that the highly conserved cluster of amino
FIG. 2. Mapping the region of FLASH required for the interaction with Lsm11. (A) Sequence alignment of the N-terminal fragment of human
(top) and Xenopus tropicalis (bottom) FLASH. The first (for N-terminal deletions) or last (for C-terminal deletions) amino acids of the truncated
versions of the human protein are indicated with arrows. (B) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear extract
(NE) alone (lane 2) or in the presence of 100 ng of either human (lane 3) or Xenopus (lane 4) N-terminal FLASH fused to GST. The substrate
alone is shown in lane 1. (C) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear extract alone (lane 2) or in the
presence of 100 ng of either human wild type (lane 3) or the LD1 mutant (lane 4) of the N-terminal human FLASH fused to GST. The substrate
alone is shown in lane 1. (D and E) Pulldown of a 35S-labeled wild-type N-terminal fragment of human Lsm11 by GST (lane 2) or GST fused to
various versions of the N-terminal fragment of human FLASH, as indicated. The input contains 10% (lane 1 in panel D) or 20% (lane 1 in panel
E) of the labeled protein used in the pulldown assay. (F and G) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear
extract alone (lane 2 in each panel) or in the presence of 100 ng of the two truncated versions of the N-terminal fragment of human FLASH fused
to GST, as indicated. The substrate alone is shown in lane 1 (each panel).
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acids 29 to 37 has no major role in processing. Strikingly,
removal of 10 additional amino acids from the N terminus
(61N mutant) completely eliminated the ability of FLASH to
stimulate processing in vitro (Fig. 4B, lane 6) but had no effect
on the interaction with Lsm11 (Fig. 4C, lane 6). The 61N
mutant displayed no processing activity even when used in an
amount 20-fold greater than that of the fully active 51N
FLASH (see Fig. S2A in the supplemental material). The
87N mutant (Fig. 4B, lane 7, and C, lane 7) and 99N
FLASH mutant (Fig. 4B, lane 11, and C, lane 8) showed the
same phenotype. As expected, no processing activity was ob-
served for the more extensive deletion mutant 110N (Fig. 4B,
lane 12). This mutant lacks 110 amino acids from the N ter-
minus, including a portion of the Lsm11 binding site, and
hence was unable to bind Lsm11 (Fig. 4C, lane 9), even when
used in an amount exceeding that of the fully proficient 28N
FLASH (see Fig. S2B in the supplemental material, bottom
panel; compare lanes 3 and 5). We conclude that the region of
FLASH located between amino acids 51 and 100 does not
critically contribute to the interaction with Lsm11 but is essen-
tial for processing and likely contains a binding site for an
undetermined processing factor(s).
We next tested the effect of adding the N-terminal FLASH
deletion mutants to processing reactions that were carried out
FIG. 3. Mutational analysis of the Lsm11 binding site in FLASH. (A) Sequence alignment of the N-terminal fragment of human (top) and
Drosophila melanogaster (bottom) FLASH. Residues of human FLASH that were changed to alanines are underlined and numbered. (B and C)
Pull down of a 35S-labeled wild-type N-terminal fragment of human Lsm11 by GST or GST fused to various mutants of the N-terminal fragment
of human FLASH, as indicated. The input contains 10% (lane 1 in panel B) or 20% (lane 1 in panel C) of the labeled protein used in the pulldown
assay. (D and E) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear extract (NE) alone (lane 2 in each panel) or
in the presence of various mutants of the N-terminal fragment of human FLASH fused to GST. Mock1 and Mock2 (lanes 9 and 10 in panel E)
are two different GST fusion proteins unrelated to 3-end processing. The substrate alone is shown in lane 1 in each panel. (F) In vitro cleavage
of the H2a pre-mRNA carried out in 7.5 l of a mouse nuclear extract alone (lanes 2 and 6) or in the presence of various mutants of the N-terminal
human FLASH fused to GST. The substrate alone is shown in lanes 1 and 5.
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for only 15 min in the presence of 7.5 l of a mouse nuclear
extract. The fully proficient 28N, 36N, and 51N FLASH
proteins did not improve the efficiency of processing, indicating
that under these reaction conditions FLASH is not limiting
(Fig. 4D, lane 3; see also Fig. 7D, lanes 3 to 5, below). In
contrast, 61N, 87N, and 99N FLASH mutants clearly had
an inhibitory effect, reducing the amount of the processed
product from 75% to less than 20% (Fig. 4D, lanes 4, 5, and
8). No inhibitory effect was observed for the further-truncated
110N mutant, which cannot bind Lsm11 (Fig. 4D, lane 9).
These results indicate that the dominant negative phenotype is
only exhibited by mutant proteins containing an intact Lsm11
binding site and lacking the highly conserved LDLYEE site
that interacts with the undetermined processing factor(s). In
addition, the dominant negative behavior of the 99N FLASH
protein demonstrates that this mutant is capable of efficiently
binding the U7 snRNP in a nuclear extract and confirms that
the upstream boundary of the core Lsm11 binding site in
FLASH is located near amino acid 100. The observation that
FLASH fragments containing the upstream site but lacking a
functional Lsm11 binding site do not inhibit processing sug-
gests that the putative factor(s) may tightly interact only with
the FLASH-Lsm11 complex. We therefore provisionally refer
to this putative processing factor as the FLASH-Lsm11-inter-
acting protein (FLIP).
Mutational analysis of the upstream site. Removal of the
conserved LDLYEE cluster at positions 55 to 60 by the 61N
deletion resulted in the loss of FLASH processing activity,
FIG. 4. Identification of a second region in FLASH required for processing. (A) Sequence alignment of the N-terminal fragment of human
(top) and Drosophila melanogaster (bottom) FLASH. Start points of the N-terminally truncated versions of human FLASH are indicated with
arrows. (B) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear extract (NE) alone (lanes 2 and 9) or in the presence
of N-terminally truncated mutants of human FLASH fused to GST, as indicated. The substrate alone is shown in lanes 1 and 8. (C) Pulldown of
a 35S-labeled wild-type N-terminal fragment of human Lsm11 by GST (lane 2) or GST fused to various N-terminally truncated mutants of human
FLASH, as indicated. The input (lane 1) contains 10% of the labeled protein used in the pulldown assay. (D) In vitro cleavage of the H2a
pre-mRNA carried out in 7.5 l of a mouse nuclear extract alone (lanes 2 and 6) or in the presence of various N-terminally truncated mutants
of human FLASH fused to GST, as indicated. The substrate is shown in lane 1.
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suggesting that some of these amino acids are critical for the
interaction with FLIP. We mutated this cluster by changing its
three consecutive amino acid pairs to alanines (Fig. 5A). We
also changed a conserved pair of amino acids, LQ, located at
positions 76 and 77. The LD2-AA mutation replacing the first
two amino acids of the cluster with alanines (amino acids 55
and 56) resulted in a slightly reduced ability to stimulate pro-
cessing compared to the fully active 28N FLASH (Fig. 5B,
compare lanes 3 and 4). The same small effect was observed
when the LD2-AA mutation was combined with a mutation in
the LD dipeptide at positions 30 and 31, in the region dispens-
able for processing (data not shown). The LY-AA mutation
located in the middle of the cluster (amino acids 57 and 58)
inhibited the processing activity of FLASH more severely (Fig.
5B, lanes 5, 10, and 15). Importantly, the double mutant LDLY
did not stimulate processing (Fig. 5B, lane 6), emphasizing the
importance of these four amino acids for the activity of
FLASH. The EE-AA mutation located at the end of the con-
served cluster (amino acids 59 and 60) did not reduce the
processing activity of FLASH (Fig. 5B, lane 11), whereas the
LQ-AA mutation at positions 76 and 77 had the same effect as
the LY-AA mutation (Fig. 5B, lanes 12 and 16). We also
generated the double mutant LYLQ. Surprisingly, this mu-
tant behaved similarly to each individual mutant and did
not display any larger reduction in processing activity (Fig. 5B,
lane 17).
All the mutations were also tested for the dominant negative
phenotype. The LY-AA and LQ-AA mutants clearly reduced
FIG. 5. Mutational analysis of the upstream binding site. (A) Sequence alignment of a binding site for the putative processing factor. Human
and Drosophila FLASH sequences are shown at the top and bottom, respectively. Residues of human FLASH that were changed to alanines are
underlined and numbered, and the start point of the 61 deletion is indicated. (B) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l
of a mouse nuclear extract (NE) alone (lanes 2, 8, and 13) or in the presence of various FLASH mutants fused to GST, as indicated. The substrate
is shown in lanes 1 and 7. (C) In vitro cleavage of the H2a pre-mRNA carried out in 7.5 l of a mouse nuclear extract alone (lanes 1 and 7) or
in the presence of various FLASH mutants fused to GST, as indicated. (D) Pulldown of a 35S-labeled N-terminal fragment of wild-type human
Lsm11 by GST (lane 2) or GST fused to various mutants of human FLASH, as indicated. The input (lane 1) contains 10% of the labeled protein
used in the pulldown assay.
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the processing efficiency of the mouse nuclear extract (Fig. 5C,
lanes 5, 9, and 11). The LDLY protein showed the greatest
inhibition of processing, consistent with its lower activity in
processing (Fig. 5C, lane 6), whereas the fully active EE-AA
mutant resulted in no inhibition (Fig. 5C, lane 10). Notably, the
dominant negative effect of the LDLY mutant was not as
strong as that of the 99N protein (Fig. 5C, compare lanes 3
and 6), suggesting that this double mutant is not fully impaired.
As expected, all proteins containing point mutations within the
upstream site bound Lsm11 with efficiency similar to that of
the wild-type FLASH (Fig. 5D and data not shown).
Search for other binding sites in FLASH. We next tested
whether the region located between the binding sites for FLIP
and Lsm11 is essential for processing. We mutated the
QMKEL cluster (amino acids 86 to 90), which is identical in
Xenopus tropicalis FLASH (Fig. 2A) and is partially conserved
in the Drosophila protein (Fig. 3A). We generated two mutant
FLASH proteins by replacing the QM and QMKEL sequences
with alanines. The QM mutant retained the normal ability to
stimulate processing in a suboptimal amount of a mouse nu-
clear extract, whereas the QMKEL protein had only slightly
reduced activity (Fig. 6B, lanes 4 and 5, respectively). The
QMKEL mutant protein was unaffected in binding Lsm11
(data not shown). We concluded that this region of FLASH is
unlikely to play a major role in processing, although it may
contribute to the maximum binding efficiency of FLIP.
As indicated above, Drosophila FLASH is unable to stimu-
late processing significantly in mammalian nuclear extracts
(Fig. 6C, lane 3). This was intriguing, since Drosophila FLASH
binds human Lsm11 and contains a sequence highly similar to
the human LDLYEE cluster. To determine the reasons for this
incompatibility, we generated two hybrid proteins by swapping
the upstream and the downstream binding elements between
human and Drosophila FLASH. We first introduced a unique
restriction site in cDNAs encoding the two FLASH orthologs,
which in both cases was located within a divergent region
located 7 to 8 amino acids upstream of the conserved aspara-
gine at the beginning of the Lsm11 core biding site (Fig. 6A).
For human FLASH, this change resulted in a single replacement
of alanine in position 67 to leucine (Hs FLASH Hind) that had no
effect on the processing activity of the protein (Fig. 6C, lane 5).
The unique HindIII site was used as a junction point to
generate the two hybrid proteins. In the Dm/Hs hybrid
FLASH, the upstream region was of Drosophila origin and the
Lsm11 binding site was from human FLASH (Fig. 6A). Inter-
estingly, this protein had normal processing activity (Fig. 6C,
lane 6), indicating that the upstream half of Drosophila FLASH
with the LDIYDD cluster can fully substitute for the corre-
sponding region of the human protein. The other hybrid pro-
tein, Hs/Dm FLASH, in which the origin of the two halves was
reversed (Fig. 6A), had the ability to stimulate processing,
although its activity was slightly lower than that of the Dm/Hs
hybrid FLASH (Fig. 6C, lane 7). Thus, the Lsm11 binding site
in Drosophila FLASH may not be as efficient in recruiting
human Lsm11 as the site present in the human protein. This
observation may explain why Drosophila FLASH does not dis-
play a dominant negative phenotype in mammalian nuclear
extracts (data not shown), as it is likely unable to compete with
the endogenous FLASH for binding Lsm11.
Overall, the swapping studies demonstrated that Drosophila
FLASH can be readily converted to a protein that is active in
mammalian nuclear extracts if at least one binding site origi-
nates from the human protein. Perhaps the two sequence ele-
ments in Drosophila FLASH function relatively inefficiently in
FIG. 6. Search for other binding sites in FLASH. (A) Amino acid sequences of Dm/Hs and Hs/Dm hybrid FLASH proteins generated by
recombining halves from human and Drosophila FLASH. The position of the unique HindIII site (the junction point of the two heterologous
sequences) is indicated with two arrowheads. Human sequences are indicated with bold fonts, and the core binding sites for FLIP and Lsm11 in
each sequence are underlined. (B and C) In vitro cleavage of the H2a pre-mRNA carried out in 0.5 l of a mouse nuclear extract (NE) alone (lane
2 in each panel) or in the presence of various FLASH proteins fused to GST, as indicated. The substrate is shown in lane 1 of each panel.
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mammalian nuclear extracts, resulting in a protein that cannot
substitute for mammalian FLASH. These studies, in conjunc-
tion with the results of mutating the QMKEL cluster, also
suggest that the region of low conservation in FLASH located
between the FLIP and Lsm11 binding sites does not play a
critical role in processing.
FLASH is dispensable for the U7-dependent degradation of
the DCP. Two products are generated as a result of endonu-
cleolytic cleavage of histone pre-mRNA by CPSF-73: the up-
stream product, corresponding to mature histone mRNA, and
the DCP, which contains the U7 binding site (19). In vitro, the
DCP is rapidly degraded by the 5 exonuclease activity of
CPSF-73 (21). 5 degradation can be studied using a presyn-
thesized DCP to uncouple the reaction from 3-end cleavage
(19). This reaction requires the U7 snRNP, is insensitive to
EDTA, and is inhibited by very low concentrations of NP-40,
hence it resembles the endonucleolytic cleavage (21).
An antibody against the N-terminal fragment of FLASH
added to a nuclear extract efficiently blocked the cleavage
reaction, with the same effect being observed for an antibody
directed against the N-terminal half of Lsm11 (20) (Fig. 7B
top, lanes 3 and 4). We tested whether degradation of the DCP
RNA (Fig. 7A) can be inhibited by the two antibodies. Sur-
prisingly, while the anti-Lsm11 antibody almost completely
blocked the degradation reaction (Fig. 7B, bottom, lane 4), the
anti-FLASH antibody had no effect (Fig. 7B, bottom, lane 3).
Consistent with this, the 28N FLASH only weakly stimulated
the degradation reaction in the presence of a limiting amount
of a nuclear extract (Fig. 7C, lane 3), although the same prep-
aration of the protein robustly increased the efficiency of the
cleavage reaction (Fig. 5B, lanes 2 and 3).
We additionally tested whether the degradation of the DCP
RNA is affected by dominant negative FLASH mutants. The
H2a and DCP RNAs were combined and processed together in
the presence of the optimal amount of nuclear extract (7.5 l)
supplemented with FLASH mutant proteins that lacked vari-
ous portions on the N terminus. The fully active 28N, 36N,
and 51N deletion proteins and the inactive proteins 110N
and LI-AA, which are unable to bind Lsm11, did not affect
processing of either RNA (Fig. 7D, lanes 3 to 5 and lanes 8 and
9). Strikingly, the 61N and 87N proteins inhibited the cleav-
age reaction but did not affect the 5 exonucleolytic degrada-
tion of the DCP RNA (Fig. 7D, lanes 6 and 7). Note that all
mutant FLASH proteins with the exception of 110N bind
Lsm11 and in nuclear extracts are likely to associate with the
U7 snRNP bound to the DCP. However, this complex neither
inhibits nor stimulates degradation of the DCP.
Finally, we tested a variant of the DCP, DCPmax, which
contains two nucleotide alterations within the HDE that allow
for uninterrupted base pairing with the U7 snRNA (Fig. 7A).
The degradation reaction was carried out for 1.5 and 15 h in
the presence of 0.5 l of the nuclear extract. Also with this
substrate, neither recombinant FLASH nor the anti-FLASH
antibody had any major effect on the efficiency of degradation
after 1.5 (Fig. 7E, lanes 3 to 5) or 15 h of incubation (Fig. 7E,
lanes 9 and 10). In contrast, the anti-Lsm11 antibody nearly
completely blocked the degradation reaction at both time
points (Fig. 7E, lanes 6 and 11). We conclude that FLASH
plays a key role in the cleavage reaction but is not required for
5 to 3 degradation of the DCP.
DISCUSSION
3-end processing of replication-dependent histone pre-
mRNAs critically depends on the U7 snRNP and its integral
component, Lsm11. The cleavage reaction is catalyzed by
FIG. 7. FLASH is dispensable for the U7-dependent degradation
of the DCP. (A) Nucleotide sequence of the DCP and DCP/max RNA
substrates. The histone downstream element that base pairs with the 5
end of U7 snRNA is underlined. Altered nucleotides in the DCP/max
that increase the complementarity to the U7 snRNA are indicated with
lowercase letters. The asterisk represents 32P label at the 5 end. (B) In
vitro cleavage of the H2a pre-mRNA (top panel) or degradation of the
DCP RNA (bottom panel) carried out in 0.75 l of a mouse nuclear
extract (NE) alone (lane 2) or in the presence of various antibodies, as
indicated. Mock antibodies 1 and 2 shown in lanes 5 and 6 were
directed against two different proteins unrelated to 3-end processing.
The substrates are shown in lane 1. (C) In vitro degradation of the DCP
RNA carried out in 0.75 l of a mouse nuclear extract alone (lanes 2)
or in the presence of the wild-type N-terminal FLASH fused to GST
(lane 3). The substrate is shown in lane 1. (D) Simultaneous in vitro
cleavage of the H2a pre-mRNA and degradation of the DCP RNA
carried out in 7.5 l of a mouse nuclear extract alone (lane 2) or in the
presence of various mutants of the N-terminal human FLASH fused to
GST, as indicated. The substrates are shown in lane 1. (E) In vitro
degradation of the DCP/max RNA carried out in 0.5 l of a mouse
nuclear extract alone (lanes 2 and 8) or in the presence of the fully
active N-terminal human FLASH (WT or 28) fused to GST or an-
tibodies, as indicated. Reaction mixtures were incubated for 1.5 (lanes
2 to 7) or 15 h (lanes 8 to 12). The mock antibody shown in lanes 7 and
12 was directed against a protein unrelated to 3-end processing. The
substrate is shown in lane 1.
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CPSF-73, which acts in conjunction with two other proteins
shared with the cleavage/polyadenylation machinery: CPSF-
100 and symplekin. Following cleavage, the DCP that interacts
with the U7 snRNP is rapidly degraded by the 5–3 exonu-
clease activity of CPSF-73. How CPSF-73, CPSF-100, and
symplekin are recruited to the processing complex containing
the U7 snRNP remains unknown. An important role in this
step may be played by the essential processing factor FLASH,
which is brought to histone pre-mRNA by binding to the N-
terminal region of Lsm11. Here we have shown that Lsm11
interacts with FLASH through a conserved region located near
its N terminus, with amino acids 25 to 40 playing a key role.
Point mutations within this region of Lsm11 abolish or signif-
icantly reduce the interaction with FLASH in vitro. Previously,
a mutation within the same region was shown to reduce pro-
cessing of a model histone pre-mRNA in Xenopus oocytes (1).
Based on our results, this effect was most likely caused by the
inability of the mutant Lsm11 and hence the U7 snRNP to
form a complex with FLASH.
Of the nearly 2,000 amino acids of human FLASH, the first
140 residues are sufficient for histone pre-mRNA processing
in vitro (20). This N-terminal region contains two conserved
sequence blocks that are required for processing: one located
between amino acids 55 and 60 and the other located be-
tween amino acids 100 and 130 (see Fig. S1 in the supple-
mental material). Mutations within the downstream conserved
element impair the interaction of FLASH with Lsm11 and
abolish the stimulatory effect of FLASH on processing. Based
on these observations, we conclude that amino acids 100 to 130
of FLASH interact with Lsm11. Residues 75 to 150 of human
FLASH are predicted to form a coiled-coil domain (11). Thus,
the entire Lsm11 binding site likely adopts an -helical struc-
ture. Point mutations or deletions within amino acids 55 to 60
of human FLASH, including the highly conserved LDLY clus-
ter, also abolish processing activity of the protein but have no
effect on binding Lsm11. Interestingly, these mutations convert
FLASH to an inhibitory protein that reduces the processing
efficiency of highly active nuclear extracts. A similar effect was
achieved by mutating the conserved dipeptide LQ at positions
76 and 77. We predict that amino acids 55 to 77 form a binding
site for a putative processing factor(s), and mutant proteins
lacking this site inhibit the cleavage reaction by engaging in a
nonproductive interaction with Lsm11, thus sequestering the
U7 snRNP present in the nuclear extract.
In contrast, FLASH mutants lacking an intact Lsm11 bind-
ing site do not act in a dominant negative manner. This obser-
vation suggests that the putative factor(s) may tightly bind
FLASH only in the presence of Lsm11 (Fig. 8). We provision-
ally refer to this factor(s) as FLIP. In the simplest scenario,
formation of the complex between FLASH and Lsm11 may
result in a structural change that makes the LDLY sequence
and the nearby region in FLASH available for the interaction
with FLIP. This interaction may be additionally stabilized by
weak contacts between FLIP and Lsm11. It is also possible that
other proteins bind to the complex of FLASH and Lsm11 and
help recruit FLIP to the LDLY cluster through a set of coop-
erative interactions. We have not determined the downstream
boundary of the FLIP binding site, although it likely extends
beyond the LQ dipeptide at positions 76 and 77 and might even
overlap with the Lsm11 binding site.
Interestingly, a sequence highly similar to the LDLY ele-
ment can also be found closer to the N terminus of human
FLASH, at positions 30 to 33. This more-upstream sequence is
conserved in all identifiable metazoan FLASH orthologs (data
not shown), although together with the entire N-terminal por-
tion of about 50 amino acids it is dispensable for processing in
vitro. It will be interesting to determine whether this sequence
plays a regulatory role in processing in vivo or is involved in an
unrelated process that exists in all metazoans.
The stimulation of in vitro cleavage of histone pre-mRNA by
FLASH is remarkable and under optimal conditions exceeds
10-fold. Strikingly, the same preparations of FLASH did not
have any significant effect on the 5 exonucleolytic degradation
of the DCP, which also depends on the U7 snRNP. Consistent
with this result, an antibody against FLASH did not affect DCP
degradation, although it nearly completely blocked the cleav-
age reaction. The lack of any major role of FLASH in DCP
degradation and the critical role of this protein in 3-end cleav-
age is the first reported difference between these two reactions
that otherwise share the same biochemical requirements, in-
cluding catalysis by the dually active nuclease CPSF-73, depen-
dence on the U7 snRNP, extreme resistance to EDTA, and
high sensitivity to very low concentrations of NP-40 (21). Al-
together, our results suggest that CPSF-73 can be recruited to
the U7 snRNP in a manner independent of FLASH. One
possibility is that CPSF-73 directly interacts with a domain in
Lsm11 that is separate from the FLASH binding site. In sup-
port of this possibility, an antibody against the N-terminal
region of Lsm11 blocks both the endonucleolytic cleavage of
histone pre-mRNA and 5 exonuclease degradation of the
DCP. The putative interaction between Lsm11 and CPSF-73
may involve two highly conserved amino acids patches in
Lsm11, PER (amino acids 107 to 109) and MPL (amino acids
148 to 150), previously shown to play an important role in
processing in Xenopus oocytes (1). We determined that mutat-
ing each of these Lsm11 sequences does not impair the inter-
action with FLASH, arguing that they likely contact another
component of the processing machinery.
FIG. 8. FLASH, Lsm11, and FLIP likely form a ternary complex.
(A) The sequences in human FLASH and Lsm11 required for the
interaction between the two proteins are boxed. The highly conserved
LDLY sequence in FLASH that interacts with FLIP is underlined.
(B) A model for the interaction between FLIP and FLASH in the
presence of Lsm11.
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How might FLASH and FLIP act to allow cleavage of his-
tone pre-mRNA by CPSF-73 without having any effect on the
5–3 exonuclease activity of CPSF-73? The stimulatory effect
of FLASH on the cleavage reaction is independent of SLBP,
suggesting that the stem-loop structure (absent from the DCP)
has no role in the stimulation (20). Moreover, our extensive
UV cross-linking studies have not detected any uncharacter-
ized protein that contacts histone pre-mRNA in a processing-
dependent manner (22). Hence, it seems unlikely that FLIP is
an RNA binding protein that indirectly facilitates the endonu-
clease activity of CPSF-73 by rigidifying the region of histone
pre-mRNA immediately upstream of the cleavage site and/or
exposing the scissile phosphodiester bond. Significantly, in the
crystal structure of a portion of human CPSF-73, the catalytic
center appears inaccessible to RNA substrates (12). This ob-
servation implies that CPSF-73 needs to undergo a structural
rearrangement prior to acquiring its enzymatic activity. There-
fore, one attractive possibility is that FLIP alone or in conjunc-
tion with FLASH directly contacts CPSF-73 and imposes ap-
propriate changes to the catalytic center so that it can function
as an endonuclease.
In the simplest case, FLIP may represent one of the previ-
ously known factors involved in 3-end processing of histone
pre-mRNAs: ZFP100, CPSF-100, symplekin, or perhaps even
the endonuclease CPSF-73. In a series of GST pull-down as-
says, we could not detect a significant interaction of FLASH
with any of these proteins when they were tested individually
(see Fig. S3 in the supplemental material). We have not been
able to obtain a soluble complex of FLASH with Lsm11 or to
express equimolar amounts of CPSF-73, CPSF-100, and
symplekin, and combination of these proteins may be required
to detect their interaction with FLASH. Thus, the question of
whether FLIP is one of the known processing factors or an
as-yet-undiscovered protein that is specific to processing of
histone pre-mRNAs remains open. Whatever the answer, de-
termining the identity of FLIP will likely provide critical in-
sights into the structure of the processing machinery and the
mechanism of the 3 cleavage reaction that forms mature his-
tone mRNAs.
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